Home  >  Products  >  ATXN3 (ataxin 3) Blocking Peptide (the N terminal of ATXN3)(100ug)
ATXN3 (ataxin 3) Blocking Peptide (the N terminal of ATXN3)(100ug)

ATXN3 (ataxin 3) Blocking Peptide (the N terminal of ATXN3)(100ug)

Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-ATXN3 Antibody(ARP50507_P050), made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Reactivities: Human
Presku: AAP50507
Size: 100ug
Weight: 41kDa
Gene: 4287
Format: Lyophilized powder
Target: Machado-Joseph disease, also known as spinocerebellar ataxia-3, is an autosomal dominant neurologic disorder. The protein encoded by this gene contains (CAG)n repeats in the coding region, and the expansion of these repeats from the normal 13-36 to 68-79 is one cause of Machado-Joseph disease. There is a negative correlation between the age of onset and CAG repeat numbers. Alternatively spliced transcript variants encoding different isoforms have been described for this gene.
Alternative names: AT3; ATX3; JOS; MJD; MJD1; SCA3
See Full Product Listings >